Literature DB >> 3678631

Early infantile epileptic encephalopathy with suppression burst: Ohtahara syndrome.

M Clarke1, J Gill, M Noronha, I McKinlay.   

Abstract

Eleven infants with neonatal onset of intractable epilepsy are described, who showed the clinical and electroencephalographic features of Ohtahara syndrome. With time, transition to West and Lennox-Gastaut syndromes occurred. No cause could be found in eight cases. All nine survivors are severely mentally and physically handicapped and continue to have seizures. Early infantile epileptic encephalopathy represents the earliest of the age-dependent epileptic encephalopathies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3678631     DOI: 10.1111/j.1469-8749.1987.tb02512.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  6 in total

Review 1.  Sex and hormonal influences on seizures and epilepsy.

Authors:  Jana Velíšková; Kara A Desantis
Journal:  Horm Behav       Date:  2012-04-04       Impact factor: 3.587

2.  Early infantile epileptic encephalopathy: a long-term follow-up study.

Authors:  A Verrotti; S Domizio; G Sabatino; G Morgese
Journal:  Childs Nerv Syst       Date:  1996-09       Impact factor: 1.475

Review 3.  Epileptic encephalopathies in early infancy.

Authors:  S Ohtahara; Y Ohtsuka; E Oka
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

4.  Anesthetic experience of a patient with Ohtahara syndrome -A case report-.

Authors:  Eun Mi Choi; Kyeong Tae Min; Jin Sun Cho; Seung Ho Choi
Journal:  Korean J Anesthesiol       Date:  2011-02-25

5.  Burst suppression in sleep in a routine outpatient EEG.

Authors:  Ammar Kheder; Matt T Bianchi; M Brandon Westover
Journal:  Epilepsy Behav Case Rep       Date:  2014-02-12

Review 6.  Emerging role of the KCNT1 Slack channel in intellectual disability.

Authors:  Grace E Kim; Leonard K Kaczmarek
Journal:  Front Cell Neurosci       Date:  2014-07-28       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.